BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24595416)

  • 1. Protection of quality and innovation in radiation oncology: the prospective multicenter trial the German Society of Radiation Oncology (DEGRO-QUIRO study). Evaluation of time, attendance of medical staff, and resources during radiotherapy with IMRT.
    Vorwerk H; Zink K; Schiller R; Budach V; Böhmer D; Kampfer S; Popp W; Sack H; Engenhart-Cabillic R
    Strahlenther Onkol; 2014 May; 190(5):433-43. PubMed ID: 24595416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial.
    Budach W; Bölke E; Fietkau R; Buchali A; Wendt TG; Popp W; Matuschek C; Sack H
    Strahlenther Onkol; 2011 Aug; 187(8):449-60. PubMed ID: 21786109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of time, attendance of medical staff and resources for radiotherapy in pediatric and adolescent patients. The DEGRO-QUIRO trial.
    Zabel-du Bois A; Milker-Zabel S; Bruns F; Christiansen H; Ernst I; Willich N; Popp W; Debus J; Sack H
    Strahlenther Onkol; 2014 Jun; 190(6):582-90. PubMed ID: 24687562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of quality and innovation in radiation oncology: the prospective multicenter trial QUIRO of DEGRO: evaluation of time, attendance of medical staff, and resources during radiotherapy with tomotherapy.
    Winkler C; Duma MN; Popp W; Sack H; Budach V; Molls M; Kampfer S
    Strahlenther Onkol; 2014 Oct; 190(10):950-6. PubMed ID: 24658604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time management in radiation oncology: evaluation of time, attendance of medical staff, and resources during radiotherapy for prostate cancer: the DEGRO-QUIRO trial.
    Keilholz L; Willner J; Thiel HJ; Zamboglou N; Sack H; Popp W
    Strahlenther Onkol; 2014 Jan; 190(1):17-25. PubMed ID: 24126939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of time, attendance of medical staff, and resources during interstitial brachytherapy for prostate cancer : DEGRO-QUIRO trial.
    Tselis N; Maurer U; Popp W; Sack H; Zamboglou N
    Strahlenther Onkol; 2014 Apr; 190(4):358-63. PubMed ID: 24638238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of time, attendance of medical staff, and resources during stereotactic radiotherapy/radiosurgery : QUIRO-DEGRO Trial.
    Zabel-du Bois A; Milker-Zabel S; Henzel M; Popp W; Debus J; Sack H; Engenhart-Cabillic R
    Strahlenther Onkol; 2012 Sep; 188(9):769-76. PubMed ID: 22847518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients. The DEGRO-QUIRO trial.
    Blank E; Willich N; Fietkau R; Popp W; Schaller-Steiner J; Sack H; Wenz F
    Strahlenther Onkol; 2012 Feb; 188(2):113-9. PubMed ID: 22241435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time management in radiation oncology: development and evaluation of a modular system based on the example of rectal cancer treatment. The DEGRO-QUIRO trial.
    Fietkau R; Budach W; Zamboglou N; Thiel HJ; Sack H; Popp W
    Strahlenther Onkol; 2012 Jan; 188(1):5-11. PubMed ID: 22194028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the attendance of medical staff and room occupancy during palliative radiotherapy.
    Adamietz IA; Micke O; Popp W; Sack H
    Strahlenther Onkol; 2014 Sep; 190(9):781-5. PubMed ID: 24820198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel.
    Müller RP; Eich HT
    Strahlenther Onkol; 2005 Sep; 181(9):557-66. PubMed ID: 16170482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the time required for overhead tasks performed by physicians, medical physicists, and technicians in radiation oncology institutions: the DEGRO-QUIRO study.
    Sack C; Sack H; Willich N; Popp W
    Strahlenther Onkol; 2015 Feb; 191(2):113-24. PubMed ID: 25245470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The QUIRO Study (assurance of quality and innovation in radiooncology): methodology, instruments and practices.
    Dunst J; Willich N; Sack H; Engenhart-Cabillic R; Budach V; Popp W
    Strahlenther Onkol; 2014 Feb; 190(2):138-48. PubMed ID: 24408057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of training in radiation oncology in Germany: where do we stand? : Results from a 2016/2017 survey performed by the working group "young DEGRO" of the German society of radiation oncology (DEGRO).
    Dietzel CT; Jablonska K; Niyazi M; Gauer T; Ebert N; Ostheimer C; Krug D
    Strahlenther Onkol; 2018 Apr; 194(4):293-302. PubMed ID: 29349604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiotherapy: current status and issues of interest.
    Intensity Modulated Radiation Therapy Collaborative Working Group
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):880-914. PubMed ID: 11704310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality assurance needs for modern image-based radiotherapy: recommendations from 2007 interorganizational symposium on "quality assurance of radiation therapy: challenges of advanced technology".
    Williamson JF; Dunscombe PB; Sharpe MB; Thomadsen BR; Purdy JA; Deye JA
    Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S2-12. PubMed ID: 18406928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assurance standards drive improvements in the profile of radiation therapy departments participating in trials of the EORTC Radiation Oncology Group.
    Grant W; Hurkmans CW; Poortmans PM; Maingon P; Monti AF; van Os MJ; Weber DC
    Radiother Oncol; 2014 Sep; 112(3):376-80. PubMed ID: 25281581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of a real time group consensus peer review process in radiation oncology: an evaluation of effectiveness and feasibility.
    Albert AA; Duggar WN; Bhandari RP; Vengaloor Thomas T; Packianathan S; Allbright RM; Kanakamedala MR; Mehta D; Yang CC; Vijayakumar S
    Radiat Oncol; 2018 Dec; 13(1):239. PubMed ID: 30509283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peer Review of Radiotherapy Planning: Quantifying Outcomes and a Proposal for Prospective Data Collection.
    Mackenzie J; Graham G; Olivotto IA
    Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):e192-e198. PubMed ID: 27633327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DEGRO practical guidelines for radiotherapy of non-malignant disorders: Part I: physical principles, radiobiological mechanisms, and radiogenic risk.
    Reichl B; Block A; Schäfer U; Bert C; Müller R; Jung H; Rödel F;
    Strahlenther Onkol; 2015 Sep; 191(9):701-9. PubMed ID: 26117368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.